Ridley Corp (ASX:RIC) share price soars 8% on resumed dividend

Ridely's financial year 2021 results came with a detailed outline of its future plans, and the market seems to like them.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ridley Corporation Ltd (ASX: RIC) share price is soaring after the company released its earnings for the financial year 2021 (FY21).

Right now, the Ridley share price is $1.23, 7.89% higher than its previous close.

Closeup of a cow eating stock feed.

Image source: Getty Images

Ridley share price jumps on 2 cent dividend

Here's how the stock feed producer performed through FY21:

Over FY21, Ridley reported $79 million of gross profit, up 18% on those of FY20. It also saw its operating cash flow increase 107% to $82.4 million.

Ridley's bulk stockfeed segment reported EBITDA before significant items of $32.4 million, down 5% from FY20. However, FY20 saw the segment's income bolstered by 'drought feeding'.

The company's packaged feeds and ingredients segment has EBITDA before significant items of $46.5 million. That represents a 32% increase on the prior corresponding period.

Additionally, the company's inventory is back to pre-COVID-19 levels.

Ridley ended the period with $39.9 million of cash and $83.1 million of debt.

What happened in FY21?

It's been a quiet run in FY21 for Ridley and its share price. Although, it did sell some assets.

The company sold surplus land at Lara and Moolap for a pre-tax profit of $3.7 million.

In April, it also sold its wholly owned, non-operating, and Singapore-incorporated subsidiary Novacq International Pte Ltd for no profit or loss.

Ridley also announced it was to sell its Tasmanian extrusion facility in May. However, the sale was finalised after the financial year ended.

What's next for Ridley?

Here's what might drive the Ridley share price in FY22:

Ridley's FY21 included several sales that have occurred since the end of the financial year just been and will be added to its FY22 results.

First off, the company sold its Tasmania-based Westbury extrusion plant for $54.85 million earlier this month. A $7 million profit from the sale will be noted in Ridley's FY22 results.

Additionally, a $2.2 million contract for the sale of its former feedmill at Bendigo was signed on 27 July. Another sale contract, this time for its former feed mill at Mooroopna worth $1.65 million, was completed on 13 August.

The sales will generate a pre-tax gain on sale of around $2.6 million in FY22.

Ridley also outlined its growth plan in its FY21 results.

The company plans to undergo a $4 million plant commissioning in the first half of FY22. The plant will produce land animal protein concentrates.

Ridley will also launch Food for Dogs in speciality pet stores in April, and its Cobber range into rural grocery from the first half of FY22. Additionally, it plans to supply grocery house brands in FY22. It expects to launch a Novacq prawn feed, developed by CSIRO, in FY22.

The company will also increase its asset utilisation and expand its Narangba facility.

Finally, it plans to launch its Ridley Direct, which will see an ingredients sales desk selling to livestock producers who mix feed on farm.

Additionally, Ridley plans to spend $15 million over FY22 and FY23 on a series of small projects to extend its product offerings, de-bottleneck its capacity, and reduce costs.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Earnings Results

Doctor doing a telemedicine using laptop at a medical clinic
Earnings Results

Guess which ASX 200 stock is jumping 9% on FY26 results

This medical device company has released its FY 2026 results. Let's see what it reported.

Read more »

A man sitting in an aeroplane seat holds the top of his head as he looks at his airline ticket with an annoyed, angry expression on his face.
Earnings Results

Webjet shares crash 15% as Virgin Australia blow hits outlook

Webjet shares are under heavy pressure after its latest update.

Read more »

A man sitting at his desktop computer leans forward onto his elbows and yawns while he rubs his eyes as though he is very tired.
Earnings Results

James Hardie shares tumble on FY26 profit crunch

Investors have been hitting the sell button on Wednesday. Let's find out why.

Read more »

a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
Earnings Results

Why are Catapult Sport shares jumping 18% today?

This sports technology company has delivered a stronger than expected FY 2026 result.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Earnings Results

Which ASX 200 share is crashing 22% on half-year results?

Let's see why investors are hitting the sell button on Monday.

Read more »

A man in a suit looks surprised as he looks through binoculars.
Earnings Results

Guess which ASX 200 stock is dropping despite record quarterly profit

It was a record-breaking quarter for this company.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Earnings Results

Why Xero shares are falling despite a big jump in revenue

Xero shares are under pressure as Melio costs weigh on profit.

Read more »

A man looking at his laptop and thinking.
Earnings Results

ASX 200 stock crashes 12% on half-year results

Profit is down but its guidance has been reaffirmed.

Read more »